Comparison of endothelial function in patients with metabolic syndrome on bezafibrate or atorvastatin therapy.
Hanefeld
Christoph
C
Heart and Vascular Center Bochum, Department of Medicine II, St. Josef-Hospital, University of Bochum, Germany.
Bulut-Streich
Nadine
N
Bulut
Daniel
D
Graf
Claudia
C
Mügge
Andreas
A
Spiecker
Martin
M
D000368:Aged; D000069059:Atorvastatin; D001629:Bezafibrate / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood / Q000187:drug effects; D008078:Cholesterol, LDL / Q000097:blood / Q000187:drug effects; D003326:Coronary Circulation / Q000187:drug effects; D004730:Endothelium, Vascular / Q000187:drug effects* / Q000503:physiopathology*; D005542:Forearm / Q000098:blood supply; D006538:Heptanoic Acids / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D015228:Hypertriglyceridemia / Q000188:drug therapy / Q000503:physiopathology; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008297:Male; D024821:Metabolic Syndrome / Q000188:drug therapy* / Q000503:physiopathology*; D008875:Middle Aged; D011758:Pyrroles / Q000627:therapeutic use*; D012039:Regional Blood Flow / Q000187:drug effects; D016896:Treatment Outcome; D014664:Vasodilation / Q000187:drug effects
D015415:Biomarkers; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D011758:Pyrroles; D000069059:Atorvastatin; D001629:Bezafibrate